| InChI Key | OEYIOHPDSNJKLS-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C5H14NO+ |
| Molecular Weight | 104.17 |
| AlogP | -0.32 |
| Hydrogen Bond Acceptor | 1.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 20.23 |
| Molecular species | None |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 7.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | 3013006.02 | - | - | - | |
|
Ion channel
Ligand-gated ion channel
Nicotinic acetylcholine receptor
Nicotinic acetylcholine receptor alpha subunit
|
- | - | - | 18000 | - | |
|
Ion channel
Ligand-gated ion channel
Nicotinic acetylcholine receptor
Nicotinic acetylcholine receptor beta subunit
|
- | - | - | 18000 | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC05 family of sodium-dependent glucose transporters
|
- | 1600 | - | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC06 neurotransmitter transporter family
|
- | - | - | 42000 | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC22 family of organic cation and anion transporters
|
- | 159000-1450000 | - | - | 21.3 |
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Inflammation; Pain, Postoperative | Phase 4 | ClinicalTrials |